Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P21
Within normal range
vs 5Y Ago
-3.7x
Contraction
Streak
1 yr
Consecutive growthDecelerating
PeriodValue
2025-27.88%
2024-27.91%
2023-3.02%
202270.95%
202175.99%
20207.58%
2019-4.74%
2018-4.18%
2017-3.39%
201611.87%